[go: up one dir, main page]

GT200600257A - Inhibidor de tubulina y proceso para su preparacion - Google Patents

Inhibidor de tubulina y proceso para su preparacion

Info

Publication number
GT200600257A
GT200600257A GT200600257A GT200600257A GT200600257A GT 200600257 A GT200600257 A GT 200600257A GT 200600257 A GT200600257 A GT 200600257A GT 200600257 A GT200600257 A GT 200600257A GT 200600257 A GT200600257 A GT 200600257A
Authority
GT
Guatemala
Prior art keywords
tubulin inhibitor
preparation
hemifumarate
mettiletil
propoxi
Prior art date
Application number
GT200600257A
Other languages
English (en)
Spanish (es)
Inventor
David Michael Blum
Yanzhong Wu
Jean Schmid
Timothy John Doyle
Jay Thomas Afragola
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37074929&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GT200600257(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of GT200600257A publication Critical patent/GT200600257A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GT200600257A 2005-06-13 2006-06-13 Inhibidor de tubulina y proceso para su preparacion GT200600257A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US69001605P 2005-06-13 2005-06-13
US80278106P 2006-05-24 2006-05-24

Publications (1)

Publication Number Publication Date
GT200600257A true GT200600257A (es) 2007-02-14

Family

ID=37074929

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200600257A GT200600257A (es) 2005-06-13 2006-06-13 Inhibidor de tubulina y proceso para su preparacion

Country Status (12)

Country Link
EP (1) EP1891052A1 (fr)
JP (1) JP2008543838A (fr)
AR (1) AR054392A1 (fr)
AU (1) AU2006259663A1 (fr)
BR (1) BRPI0612145A2 (fr)
CA (1) CA2610416A1 (fr)
GT (1) GT200600257A (fr)
MX (1) MX2007015718A (fr)
PE (1) PE20070114A1 (fr)
SV (1) SV2007002573A (fr)
TW (1) TW200716613A (fr)
WO (1) WO2006138180A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9163060B2 (en) 2009-11-12 2015-10-20 R&D Biopharmaceuticals Gmbh Tubulin inhibitors
WO2014047257A2 (fr) * 2012-09-19 2014-03-27 The Trustees Of The University Of Pennsylvania Composés hétérocycliques et leur utilisation pour le traitement de tauopathies neurodégénératives
WO2017181974A1 (fr) * 2016-04-20 2017-10-26 苏州苏领生物医药有限公司 Composé hétérocyclique à cinq chaînons, procédé de préparation correspondant, composition pharmaceutique et utilisation
WO2019169111A1 (fr) 2018-03-02 2019-09-06 The Trustees Of The University Of Pennsylvania Composés de [1,2,4]triazolo[1,5-a]pyrimidine et utilisation de ces derniers dans la stabilisation de microtubules

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0414700A (pt) * 2003-09-24 2006-11-14 Wyeth Corp 6-[(substituìdo)fenil]triazolopirimidinas como agentes anti-cáncer
MXPA06003207A (es) * 2003-09-24 2006-06-23 Wyeth Corp 5-arilpirimidinas como agentes anti-cancer.

Also Published As

Publication number Publication date
WO2006138180A1 (fr) 2006-12-28
EP1891052A1 (fr) 2008-02-27
AU2006259663A1 (en) 2006-12-28
CA2610416A1 (fr) 2006-12-28
MX2007015718A (es) 2008-02-21
TW200716613A (en) 2007-05-01
BRPI0612145A2 (pt) 2010-10-19
JP2008543838A (ja) 2008-12-04
SV2007002573A (es) 2007-01-03
PE20070114A1 (es) 2007-02-03
AR054392A1 (es) 2007-06-20

Similar Documents

Publication Publication Date Title
CL2007002384A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento de la psoriasis.
CR20140313A (es) Compuestos de biaril éter urea
BRPI0817307A2 (pt) Processo para a fabricação de uma chapa de metal.
HN2006000971A (es) Metodos para preparar composiciones o formas de dosificacion que comprenden un agonista grp119 que tiene el efecto de un secretagogo glp-1
MX2009005004A (es) Microorganismos o fracciones de los mismos capaces de activar inmunidad celular contra carbohidratos.
CL2007002380A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento terapeutico y/o profilactico de la queratosis actinica.
CL2016002589A1 (es) Uso del compuesto genz-112638 (eliglustat), inhibidor de glucosilceramida sintasa, en el tratamiento de la enfermedad de gaucher y enfermedad de fabry (divisional de solicitud 201201348).
DE602006020327D1 (de) 2-phenoxy-n-(1,3,4-thiadizol-2-yl)pyridin-3-aminder-hemmer zur behandlung thromboembolischer erkrankungen
AR058753A1 (es) Uso de composiciones nutricionales con fosfolipidos esfingolipidos y colesterol
BR122018068717B8 (pt) processos para a síntese de agomelatina
UY30846A1 (es) Derivados de oxindol sustituidos, medicamentos que los comprenden y uso de los mismos
MX2008002293A (es) Uso novedoso de compuestos peptidicos para tratar dolor muscular.
BRPI0408922B1 (pt) processo para o tratamento termomecánico de aço.
PT1938647T (pt) Técnica para execução de um procedimento de acesso aleatório através de uma interface rádio
BRPI0709769B8 (pt) implantes biodegradáveis para o tratamento de estados associados à dopamina
CL2007002387A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento de artritis y dolor.
NO20076186L (no) Mitotiske kinesininhibitorer og fremgangsmater for anvendelse derav
BRPI0606118A2 (pt) uma sìntese assimétrica de (s) - (+) -3- (aminometil) -5- ácido metilhexanóico
UY29774A1 (es) Inhibidor de atm
GT200600257A (es) Inhibidor de tubulina y proceso para su preparacion
AR058579A1 (es) Proceso para preparar desvenlafaxina
GT200800066A (es) Derivados de 9-cloro-15-deoxiprostaglandina, procedimiento para su preparacion y su uso como medicamento.
CL2008000093A1 (es) Compuestos derivados de piridina, inhibidores de p2y12; composicion farmaceutica que comprende a dichos compuestos; y su uso para el tratamiento de un desorden de agregacion plaquetaria.
AR064219A1 (es) Cuerpo moldeado que contiene titanio
UY29790A1 (es) Sales de diariloimidazola-4-carboxamidas, composiciones que las contienen, procesos de preparación y aplicaciones